All In Biotech

Free tool

FAERS Monitor: Sympazan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210833 or its brand name (Sympazan, Clobazam). Reports on generic versions are filed under their own applications.

Reports

17,678

Serious

15,318

87% of reports

Hospitalization

6,630

Death reported

1,245

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure3,075
  • drug ineffective2,717
  • off label use1,949
  • somnolence1,356
  • drug interaction1,059
  • epilepsy810
  • condition aggravated760
  • fatigue742
  • status epilepticus625
  • multiple-drug resistance584
  • generalised tonic-clonic seizure530
  • foetal exposure during pregnancy520
  • toxicity to various agents476
  • fall469
  • decreased appetite460

Reports by year received

View as table
YearReports
200446
200573
200669
200784
2008111
2009127
2010168
2011127
2012299
2013273
2014296
2015392
2016385
2017542
2018894
20191,315
20201,354
20212,018
20221,616
20231,958
20242,167
20251,945
20261,418

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,481 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple-drug resistanceSignal584275.8252.3129,600
status epilepticusSignal62569.764.339,913
generalised tonic-clonic seizureSignal53039.336.119,144
seizureSignal3,07532.531.591,896
epilepsySignal81032.430.223,963
somnolenceSignal1,3568.17.78,402
drug interactionSignal1,0598.07.56,473
foetal exposure during pregnancySignal5207.77.02,994
toxicity to various agentsSignal4763.43.1793
condition aggravatedSignal7603.02.81,009
off label useSignal1,9492.72.52,086
drug ineffectiveSignal2,7172.52.42,495
decreased appetiteSignal4602.42.2362
fall4691.71.5130
fatigue7421.11.112

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.